港股異動 | 協合新能源(0182.HK)大漲逾13% 中期純利升6.3%至4.03億
格隆匯8月5日丨協合新能源(0182.HK)午後大幅拉昇漲超13%,報0.68港元創2014年4月以來新高價,成交額放大至5879萬港元,總市值57億港元。協合新能源午間公佈,上半年集團實現收入9.70億元,同比下降2.9%;權益持有人應占溢利4.03億元,同比上升6.3%;基本每股盈利4.90分,不派中期股息。報吿期內,集團權益發電量實現同比增長,較上年同期增長8.1%。截至2021年6月30日,集團持有67間併網發電的風電及光伏電廠股權,總裝機容量達3346MW。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.